Lifecore Biomedical, Inc. (NASDAQ: LFCR) is a Healthcare company (Drug Manufacturers - Specialty & Generic) with a market capitalization of $242M. The Maz Rating grades it against the other companies in its sector.
Lifecore Biomedical, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $6.39, Lifecore Biomedical, Inc. trades at 2.1x sales. Over the last twelve months it generated about $117M of revenue and a net loss of $72M. It runs a gross margin of 30.3%, an operating margin of -0.4% and a net margin of -57.7%. It shows return on equity of 381.6%, return on invested capital of -0.2% and a free cash flow yield of 2.1%. On the balance sheet: a debt-to-equity ratio of -3.04 and a current ratio of 3.84. Over the past 52 weeks the share price ranged from $3.63 to $8.98, with a beta of 0.99.
Lifecore Biomedical, Inc. does not currently pay a dividend.
8 Wall Street analyst ratings cover the stock: 4 Buy and 4 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.